Anal Carcinoma
Conditions
Brief summary
Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point. This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.
Interventions
DIAGNOSTIC_TESTMRI sequence
several MRI sequence before and after contrast product injection.
Sponsors
Fondation Hôpital Saint-Joseph
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* patient with anal canal cell carcinoma histologically proved * patient with initial MRI and follow up MRI in Hospital St Joseph's radiology yard. * patient for whom a radio chemotherapy treatment decision was taken.
Exclusion criteria
* patients with already metastatic lesions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Distance with regard to the anal margin | maximum of 6 years after the initial MRI | tumor position |
| initial tumor size | maximum of 6 years after the initial MRI | Maximal tumoral size in the cranio-caudal plan in cm |
| presence of nodal status | maximum of 6 years after the initial MRI | presence of nodal status in inguinal region |
Countries
France
Outcome results
None listed